Jiro Seki

1.4k total citations
66 papers, 1.2k citations indexed

About

Jiro Seki is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Jiro Seki has authored 66 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Cardiology and Cardiovascular Medicine and 14 papers in Hematology. Recurrent topics in Jiro Seki's work include Platelet Disorders and Treatments (11 papers), Inflammatory mediators and NSAID effects (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Jiro Seki is often cited by papers focused on Platelet Disorders and Treatments (11 papers), Inflammatory mediators and NSAID effects (11 papers) and Antiplatelet Therapy and Cardiovascular Diseases (9 papers). Jiro Seki collaborates with scholars based in Japan, United States and Spain. Jiro Seki's co-authors include Yukio Motoyama, Toshiaki Aoki, Keizo Yoshida, Dermot Cox, Mie Nishio, Toshio Goto, Yasuko Kato, Ikuo Kawamura, Seitaro Mutoh and Toshio Yamanaka and has published in prestigious journals such as Blood, Circulation Research and Biochemical and Biophysical Research Communications.

In The Last Decade

Jiro Seki

64 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiro Seki Japan 19 351 256 232 231 175 66 1.2k
Repin Vs Russia 22 511 1.5× 194 0.8× 189 0.8× 460 2.0× 146 0.8× 136 1.5k
Lucia Stefanini Italy 23 379 1.1× 747 2.9× 340 1.5× 192 0.8× 263 1.5× 47 1.5k
Órla P. Barry Ireland 14 965 2.7× 437 1.7× 229 1.0× 131 0.6× 78 0.4× 21 1.9k
Stefano Manarini Italy 22 485 1.4× 679 2.7× 423 1.8× 184 0.8× 365 2.1× 36 2.1k
Agostino Faggiotto United States 8 288 0.8× 92 0.4× 299 1.3× 560 2.4× 200 1.1× 12 1.5k
Carl Whatling Sweden 23 383 1.1× 109 0.4× 276 1.2× 236 1.0× 64 0.4× 44 1.5k
Lenore B. Safier United States 10 307 0.9× 290 1.1× 241 1.0× 165 0.7× 79 0.5× 12 1.2k
Su-Ning Zhu Canada 15 601 1.7× 61 0.2× 212 0.9× 313 1.4× 326 1.9× 18 2.0k
Kenji Kuwabara Japan 14 315 0.9× 70 0.3× 133 0.6× 92 0.4× 52 0.3× 23 938
Sean Y. Kassim United States 8 300 0.9× 89 0.3× 111 0.5× 125 0.5× 56 0.3× 9 1.0k

Countries citing papers authored by Jiro Seki

Since Specialization
Citations

This map shows the geographic impact of Jiro Seki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiro Seki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiro Seki more than expected).

Fields of papers citing papers by Jiro Seki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiro Seki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiro Seki. The network helps show where Jiro Seki may publish in the future.

Co-authorship network of co-authors of Jiro Seki

This figure shows the co-authorship network connecting the top 25 collaborators of Jiro Seki. A scholar is included among the top collaborators of Jiro Seki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiro Seki. Jiro Seki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shimada, Keisuke, et al.. (2015). Prolonged rest period enables the detection of micronucleated hepatocytes in the liver of young adult rats after a single dose of diethylnitrosamine or mitomycin C. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 791. 38–41. 3 indexed citations
2.
Arai, Hiroyuki, Shunsuke Tawara, Shinsuke Itoh, et al.. (2014). Disease animal models for drug research and development. Folia Pharmacologica Japonica. 144(3). 126–132.
3.
Tawara, Shunsuke, Nobuyoshi Kobayashi, Hiroyuki Arai, et al.. (2014). Requirements for the license-out of drug candidates to pharmaceutical companies. Folia Pharmacologica Japonica. 143(4). 198–202. 1 indexed citations
4.
Mitamura, Takashi, Yuko Doi, Mayumi Kawabe, et al.. (2010). Inhibitory potency of tacrolimus ointment on skin tumor induction in a mouse model of an initiation-promotion skin tumor. The Journal of Dermatology. 38(6). 562–570. 5 indexed citations
5.
Sakuma, Shozo, et al.. (2007). Effect of tacrolimus on the cauda epididymis in rats: Analysis of epididymal biochemical markers or antioxidant defense enzymes. Toxicology. 243(1-2). 23–30. 18 indexed citations
6.
Tanaka, Akira, Kouji Hattori, Osamu Okitsu, et al.. (2006). Replacing the cyclohexene-linker of FR181157 leading to novel IP receptor agonists: Orally active prostacyclin mimetics. Part 6. Bioorganic & Medicinal Chemistry Letters. 16(18). 4861–4864. 10 indexed citations
7.
Hattori, Kouji, et al.. (2005). Discovery of new diphenyloxazole derivatives containing a pyrrolidine ring: Orally active prostacyclin mimetics. Part 2. Bioorganic & Medicinal Chemistry Letters. 15(13). 3279–3283. 8 indexed citations
8.
Hattori, Kouji, Akira Tanaka, Hisashi Takasugi, et al.. (2005). Metabolism investigation leading to novel drug design: Orally active prostacyclin mimetics. Part 4. Bioorganic & Medicinal Chemistry Letters. 15(13). 3284–3287. 2 indexed citations
9.
Hattori, Kouji, Akira Tanaka, Osamu Okitsu, et al.. (2005). Discovery of diphenylcarbamate derivatives as highly potent and selective IP receptor agonists: Orally active prostacyclin mimetics. Part 3. Bioorganic & Medicinal Chemistry Letters. 15(12). 3091–3095. 14 indexed citations
10.
Mihara, Kayoko, Toshiaki Aoki, Akira Moriguchi, et al.. (2004). Characterization of the anti‐platelet actions of FK419, a novel non‐peptide antagonist of platelet GPIIb/IIIa. Drug Development Research. 61(4). 233–241. 23 indexed citations
11.
Kato, Yasuko, Yasuhiro Kita, Mie Nishio, et al.. (2003). Inhibition of arterial thrombosis by a protease-activated receptor 1 antagonist, FR171113, in the guinea pig. European Journal of Pharmacology. 473(2-3). 163–169. 75 indexed citations
12.
Hosogai, Naomi, Jiro Seki, & Toshio Goto. (2001). Reciprocal regulation of cyclic GMP content by cyclic GMP‐phosphodiesterase and guanylate cyclase in SHR with CsA‐induced nephrotoxicity. British Journal of Pharmacology. 134(5). 995–1002. 7 indexed citations
13.
Inoue, Takeshi, Ikuo Kawamura, Masahiko Matsuo, et al.. (2000). LESSER REDUCTION IN BONE MINERAL DENSITY BY THE IMMUNOSUPPRESSANT, FK506, COMPARED WITH CYCLOSPORINE IN RATS. Transplantation. 70(5). 774–779. 44 indexed citations
14.
Setoi, Hiroyuki, Akio Kuroda, A. Sawada, et al.. (1999). synthesis and biological activity of 4-methyl-3,5-dioxane derivatives as thromboxane a2 receptor antagonists. Bioorganic & Medicinal Chemistry. 7(11). 2635–2645. 11 indexed citations
15.
Kato, Yasuko, Yasuhiro Kita, Mie Nishio, et al.. (1999). In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist. European Journal of Pharmacology. 384(2-3). 197–202. 46 indexed citations
16.
Aoki, Toshiaki, Dermot Cox, Jiro Seki, et al.. (1996). The anti-platelet and anti-thrombotic effects of FK633, a peptide-mimetic antagonist. Thrombosis Research. 81(4). 439–450. 30 indexed citations
17.
Hirasawa, Yoshimi, Toshiko Sugimoto, Yasuko Kato, et al.. (1996). Antianginal effects of FR144420, a novel slow nitric oxide-releasing agent. European Journal of Pharmacology. 303(1-2). 55–59. 8 indexed citations
18.
Motoyama, Yukio, et al.. (1994). Effect of TFC-612, a 7-thia prostaglandin El derivative, on intimal thickening after endothelial injury with balloon catheter in rats. Atherosclerosis. 108(2). 159–165. 6 indexed citations
19.
Ota, Akemi, Jiro Seki, Yu Zhao, et al.. (1993). characteristics of the Epitope of Protein-Reactive Anti-Peptide Antibodies. The Journal of Biochemistry. 113(3). 314–320. 5 indexed citations
20.
Motoyama, Yukio, et al.. (1992). TFC-612, a prostaglandin E1 derivative, enhances fibrinolytic activity in rats. Thrombosis Research. 65(1). 55–63. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Repin Vs Breakdown of academic impact, for papers by Lucia Stefanini Breakdown of academic impact, for papers by Órla P. Barry Breakdown of academic impact, for papers by Stefano Manarini Breakdown of academic impact, for papers by Agostino Faggiotto Breakdown of academic impact, for papers by Carl Whatling Breakdown of academic impact, for papers by Lenore B. Safier Breakdown of academic impact, for papers by Su-Ning Zhu Breakdown of academic impact, for papers by Kenji Kuwabara Breakdown of academic impact, for papers by Sean Y. Kassim
Rankless by CCL
2026